Frequently asked questions.
For general questions about Axolotl Biologix and our products, please see our FAQs below.
*All information is subject to change or be modified based on regulatory requirements.
General Questions
For general questions about Axolotl Biologix, including information about our company and operations, please see our FAQs to the right.
Axolotl Biologix specializes in developing advanced human amnion graft products that enhance wound care and tissue repair. Our innovative solutions leverage the natural regenerative properties of amnion to provide superior healing outcomes.
We maintain rigorous quality control processes and comply with all relevant regulatory standards to ensure the highest levels of safety and efficacy. Our commitment to quality is backed by peer-reviewed research and ongoing clinical trials.
Axolotl Biologix distinguishes itself through its commitment to innovation, quality, and comprehensive market access. Our products are backed by robust clinical evidence and designed for use in diverse care settings, ensuring broad accessibility and superior patient outcomes.
Healthcare providers can order our products by contacting our sales team through the contact information provided on our website. We work closely with providers to ensure timely delivery and support.
To learn more about Axolotl Biologix and our innovative amnion graft products, please visit our website or reach out to us through the contact information provided. Our team is available to answer any questions and provide additional information.
Product Questions
For product questions about Axolotl Biologix, including information about our quality and clinical work, please see our FAQs to the right.
Amnion graft products are derived from the amniotic membrane, which naturally possesses anti-inflammatory, anti-scarring, and regenerative properties. These products are used to promote faster and more effective healing in various medical applications.
Axolotl Biologix's amnion graft products enhance healing and recovery by reducing inflammation, promoting tissue regeneration, and accelerating wound healing. The grafts are effective in covering a wide range of wound conditions, providing significant benefits to patients across various clinical settings.
Yes, our products are supported by extensive peer-reviewed research and clinical studies. We have multiple published papers demonstrating the efficacy and safety of our amnion graft products, including a currently enrolling Randomized Controlled Trial (RCT).
Our products are versatile and can be used in multiple care settings, including hospitals, outpatient clinics, and specialized wound care centers. They are designed to be accessible to a wide range of healthcare providers and patients.
Yes, our amnion graft products are used in the treatment regime of diabetic and chronic wounds. They may help reduce inflammation, promote tissue regeneration and aid in the acceleration process, making them an ideal solution for diabetic wound management.
